Clinical Trial Update: Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravitreal sirolimus for geographic atrophy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Geographic Atrophy | Phase 2 | Status: TERMINATED